4
Changes in Ownership
Oruka Therapeutics, Inc. Filed Acc 0000907654-26-000116
Senior Vice President, Finance sold 10,000 shares at an average $104.97 ($1,049,658)
- Senior Vice President, Finance acquired 10,000 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Agarwal Arjun Senior Vice President, Finance | 2026-11-12 | Option exercise 10b5-1 | +8,542 | $12.50 | $106,775 | 22,761 | D: show line 1 in the form |
| Agarwal Arjun Senior Vice President, Finance | 2026-11-12 | Option exercise 10b5-1 | +1,458 | $34.39 | $50,141 | 24,219 | D: show line 2 in the form |
| Agarwal Arjun Senior Vice President, Finance | 2026-11-12 | Sale 10b5-1 | −500 | $101.98 | $50,988 | 23,719 | D: show line 3 in the form |
| Agarwal Arjun Senior Vice President, Finance | 2026-11-12 | Sale 10b5-1 | −801 | $103.16 | $82,628 | 22,918 | D: show line 4 in the form |
| Agarwal Arjun Senior Vice President, Finance | 2026-11-12 | Sale 10b5-1 | −799 | $104.25 | $83,296 | 22,119 | D: show line 5 in the form |
| Agarwal Arjun Senior Vice President, Finance | 2026-11-12 | Sale 10b5-1 | −6,842 | $105.28 | $720,330 | 15,277 | D: show line 6 in the form |
| Agarwal Arjun Senior Vice President, Finance | 2026-11-12 | Sale 10b5-1 | −958 | $106.18 | $101,717 | 14,319 | D: show line 7 in the form |
| Agarwal Arjun Senior Vice President, Finance | 2026-11-12 | Sale 10b5-1 | −100 | $107.00 | $10,700 | 14,219 | D: show line 8 in the form |
| Open-market sales · 10,000 sh · avg $104.97 · $1,049,658 | |||||||
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|
| Agarwal Arjun Senior Vice President, Finance | 2026-11-12 | Option exercise · Employee Stock Option (right to buy) 10b5-1 | −8,542 | 67,834 | D: show line 9 in the form | |||||
| Agarwal Arjun Senior Vice President, Finance | 2026-11-12 | Option exercise · Employee Stock Option (right to buy) 10b5-1 | −1,458 | 55,417 | D: show line 10 in the form |
Loading xslF345X06/form4.xml…